Can breast cancer patients use soyafoods to help reduce risk of CHD?

5Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.

Abstract

Over the past 20 years, the popularity of soyafoods has increased in part because of research suggesting that these foods convey health benefits independent of their nutrient content. For example, in 1999, the US Food and Drug Administration approved a health-claim for soyafoods and CHD based on the hypocholesterolaemic effects of soya protein. However, soyafoods have become controversial in recent years because of concerns that their uniquely rich phyto-oestrogen (isoflavone) content may cause untoward effects in some individuals. Most notable in this regard is the concern that soyafoods are contraindicated for breast cancer patients and women at high risk of developing this disease. Furthermore, the hypocholesterolaemic effects of soya protein have been challenged. However, the results of recently published meta-analyses indicate that soya protein directly lowers circulating LDL-cholesterol levels by approximately 4 %. There is also intriguing evidence that soyafoods reduce CHD risk independent of their effects on lipid levels. In regard to the breast cancer controversy, recently published clinical and epidemiological data do not support observations in rodents that soyabean isoflavones increase breast cancer risk. In postmenopausal women, isoflavone exposure does not adversely affect breast tissue density or breast cell proliferation. Furthermore, both US and Chinese prospective epidemiological studies show that post-diagnosis soya consumption is associated with an improved prognosis. Therefore, soyafoods should be considered by women as healthy foods to include in diets aimed at reducing the risk of CHD regardless of their breast cancer status. © 2011 The Authors.

References Powered by Scopus

Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)

25666Citations
N/AReaders
Get full text

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women's health initiative randomized controlled trial

14827Citations
N/AReaders
Get full text

Effects of Conjugated Equine Estrogen in Postmenopausal Women with Hysterectomy: The Women's Health Initiative Randomized Controlled Trial

4369Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Rapid magnetic solid-phase extraction for the selective determination of isoflavones in soymilk using baicalin-functionalized magnetic nanoparticles

36Citations
N/AReaders
Get full text

A modified QuEChERS method coupled with high resolution LC-Q-TOF-mass spectrometry for the extraction, identification and quantification of isoflavones in soybeans

8Citations
N/AReaders
Get full text

Letters to the Editor

1Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Messina, M., Messina, V., & Jenkins, D. J. A. (2012, September 14). Can breast cancer patients use soyafoods to help reduce risk of CHD? British Journal of Nutrition. https://doi.org/10.1017/S0007114512001900

Readers over time

‘13‘14‘16‘17‘18‘19‘20‘21‘22‘23‘24‘2502468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 16

67%

Researcher 4

17%

Professor / Associate Prof. 2

8%

Lecturer / Post doc 2

8%

Readers' Discipline

Tooltip

Medicine and Dentistry 16

67%

Agricultural and Biological Sciences 4

17%

Nursing and Health Professions 2

8%

Sports and Recreations 2

8%

Save time finding and organizing research with Mendeley

Sign up for free
0